生物防御市场规模、份额、成长分析、按类型、应用、按地区 - 产业预测，2024-2031 年

Biodefense Market Size, Share, Growth Analysis, By Type (Anthrax, Smallpox), By Application (Hospitals and clinics, Ambulatory care centers), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球生物防御市场规模为152.2亿美元，从2023年的159.9亿美元成长到2031年的236.7亿美元，预测期（2024-2031）预计复合年增长率为5.03%。

由于生技药品的威胁不断增加以及对有效准备和应对策略的需求不断增长，全球生物防御市场近年来经历了显着的成长和转型。生物防御涵盖广泛的活动和技术，旨在应对与生物恐怖主义、流行病和其他生物紧急情况相关的风险。这个市场包括疫苗、治疗、检测和诊断以及防护工具等各个领域。对生物防御解决方案的需求不断增长，反映出人们越来越意识到生物攻击和爆发的潜在破坏性影响，并推动世界各国政府大力投资生物防御能力。基因组学、合成生物学和资料分析等技术的进步正在推动创新和复杂的生物防御产品的开发。政府、国防机构和私人组织之间的合作也正在推动全面的生物防御战略和市场成长。然而，监管障碍、高昂的研发成本以及生物防御威胁的复杂性等挑战构成了重大障碍。儘管存在这些挑战，但随着各国优先考虑并投资加强生物防御措施，市场预计将继续扩大。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

XOMA Corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation
SIGA Technologies
Elusys Therapeutics Inc.
Ichor Medical Systems
Dynport Vaccine Company
Cleveland Biolabs
Bavarian Nordic
Ology Bioservices
Alnylam Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc.
PharmAthene Inc.
Profectus Biosciences Inc.
NanoViricides Inc.
Takeda Pharmaceutical Company Limited
Sanofi Pasteur
GlaxoSmithKline

简介目录

Product Code: SQMIG35H2213

Global Biodefense Market size was valued at USD 15.22 billion in 2022 and is poised to grow from USD 15.99 billion in 2023 to USD 23.67 billion by 2031, growing at a CAGR of 5.03% during the forecast period (2024-2031).

The global biodefense market has experienced notable growth and transformation recently, driven by escalating threats from biological agents and the increasing need for effective preparedness and response strategies. Biodefense encompasses a broad array of activities and technologies designed to address risks related to bioterrorism, pandemics, and other biological emergencies. This market includes various sectors such as vaccines, therapeutics, detection and diagnostics, and protective equipment. The rising demand for biodefense solutions reflects heightened awareness of the potentially devastating impacts of biological attacks and outbreaks, leading governments worldwide to invest heavily in biodefense capabilities. Technological advancements, including genomics, synthetic biology, and data analytics, are enhancing the development of innovative and sophisticated biodefense products. Collaborations between governments, defense agencies, and private sector organizations are also advancing comprehensive biodefense strategies and market growth. However, challenges such as regulatory obstacles, high R&D costs, and the complex nature of biodefense threats present significant hurdles. Despite these challenges, the market is expected to continue expanding as countries prioritize and invest in strengthening their biodefense measures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segmental Analysis

Global Biodefense Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others. Based on Application, the market is segmented into Hospitals and clinics, Ambulatory care centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Biodefense Market

A major driver of the global biodefense market is the growing awareness of the severe and potentially catastrophic impacts of biological threats. In response, governments, defense agencies, and healthcare organizations around the world are making substantial investments in biodefense measures. These efforts are aimed at addressing and mitigating the risks associated with bioterrorism, pandemics, and other biological emergencies, highlighting the urgent need for enhanced preparedness and response capabilities.

Restraints in the Global Biodefense Market

A significant constraint for the Global Biodefense Market is the substantial financial burden associated with the research and development of biodefense solutions. The creation of effective vaccines, therapeutics, and detection systems demands considerable investment in areas such as research, clinical trials, and regulatory compliance. This high cost, compounded by the intricate nature of biodefense threats, makes it challenging to develop cost-effective solutions and impedes overall market growth. The financial demands and complex challenges associated with biodefense R&D can limit the pace of innovation and market expansion, further restricting progress in this critical field.

Market Trends of the Global Biodefense Market

A significant trend in the global biodefense market is the heightened emphasis on advancing diagnostic technologies. This trend reflects a growing need for rapid and precise detection of biological agents, which is crucial for early intervention and effective response during biodefense incidents. The development of innovative diagnostic tools, including point-of-care testing devices and molecular diagnostics, is central to this focus. These technologies aim to enhance both the speed and accuracy of identifying potential biological threats. By improving surveillance systems and overall preparedness, these advancements are expected to bolster response capabilities in biodefense scenarios.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Landscape
Patent Analysis
Pipeline Product Analysis
PESTEL Analysis

Biodefense Market, By Type

Market Overview
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

Biodefense Market, By Application

Market Overview
Hospitals and clinics
Ambulatory care centres
Others

Biodefense Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

XOMA Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altimmune Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent Biosolutions Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynavax Technologies Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIGA Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elusys Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ichor Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynport Vaccine Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bavarian Nordic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ology Bioservices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alnylam Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCryst Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmAthene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Profectus Biosciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoViricides Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi Pasteur
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments